Farallon Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-148,952	Closed	-$1.24M	–	124
2020 Q2	$1.24M	Buy	+148,952	New	+$1.24M	0.01%	116